Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
70 hedge funds and large institutions have $16.7M invested in Spectrum Pharmaceuticals Inc in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 25 reducing their positions, and 13 closing their positions.
245% more call options, than puts
Call options by funds: $276K | Put options by funds: $80K
7% less funds holding
Funds holding: 75 → 70 (-5)
26% less capital invested
Capital invested by funds: $22.7M → $16.7M (-$5.98M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
44% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.01M |
| 2 |
AC
Armistice Capital
New York
|
+$137K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$125K |
| 4 |
Jane Street
New York
|
+$76.5K |
| 5 |
Renaissance Technologies
New York
|
+$29.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.41M |
| 2 |
D.E. Shaw & Co
New York
|
-$1.17M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$272K |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$255K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$244K |
SPPI Hedge Fund Activity: Q4 2022 in Review
70 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2022, worth a combined $16.7M — down 26% from $22.7M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of SPPI and 8 opened new positions — a net loss of 5 holders — while 25 trimmed existing stakes and 14 added.
The largest buyer was Acadian Asset Management, adding an estimated $1.01M. The largest seller was BlackRock, cutting an estimated $1.41M.
- 70 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2022, down from 75 in Q3 2022.
- Funds reported $16.7M of Spectrum Pharmaceuticals Inc stock for Q4 2022, down 26% quarter-over-quarter.
- 8 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2022 and 13 closed out, a net change of -5 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q4 2022 was Acadian Asset Management, an estimated $1.01M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q4 2022 was BlackRock, an estimated $1.41M sold.
Based on aggregated 13F filings for Q4 2022.